Identification of biomarkers that distinguish human papillomavirus (HPV)-positive versus HPV-negative head and neck cancers in a mouse model

Proceedings of the National Academy of Sciences of the United States of America

Volumn 103, Issue 38, 2006, Pages 14152-14157

  Strati, Katerina ^a   Pitot, Henry C ^a   Lambert, Paul F ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Head and neck squamous cell carcinoma (HNSCC); Human papillomavirus 16(HPV16); Minichromosome maintenance protein 7 (MCM7); p16; Transgenic

Indexed keywords

4 NITROQUINOLINE 1 OXIDE; BIOLOGICAL MARKER; CARCINOGEN; MINICHROMOSOME MAINTENANCE PROTEIN; MINICHROMOSOME MAINTENANCE PROTEIN 7; PROTEIN P16; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CELL PROLIFERATION; CONTROLLED STUDY; EPITHELIUM CELL; HEAD AND NECK CANCER; HISTOPATHOLOGY; MOUSE; NONHUMAN; ONCOGENE; ONCOGENE E6; ONCOGENE E7; PRIORITY JOURNAL; PROTEIN EXPRESSION; RISK FACTOR; TRANSGENIC MOUSE; VIRUS INFECTION; WART VIRUS;

4-NITROQUINOLINE-1-OXIDE; ANIMALS; CARCINOGENS; CARCINOMA, SQUAMOUS CELL; CELL CYCLE PROTEINS; CELL PROLIFERATION; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DISEASE MODELS, ANIMAL; DNA-BINDING PROTEINS; EPITHELIAL CELLS; ESOPHAGUS; HEAD AND NECK NEOPLASMS; HUMAN PAPILLOMAVIRUS 16; HUMANS; MICE; MICE, TRANSGENIC; MOUTH MUCOSA; NEOPLASM METASTASIS; NUCLEAR PROTEINS; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRUS E7 PROTEINS; REPRESSOR PROTEINS; TUMOR MARKERS, BIOLOGICAL;

ANIMALIA; HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS - 16; HUMAN PAPILLOMAVIRUS TYPE 16; MUS MUSCULUS; PAPILLOMAVIRIDAE;

EID: 33749039168     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.0606698103     Document Type: Article

References (50)

1. Hunter KD, Parkinson EK, Harrison PR (2005) Nat Rev Cancer 5:127-135.
2. Chen JK, Katz RV, Krutchkoff DJ (1990) Cancer 66:1288-1296.
3. Cullen JW, Blot W, Henningfield J, Boyd G, Mecklenburg R, Massey MM (1986) Public Health Rep 101:355-373.
4. Poschl G, Seitz HK (2004) Alcohol Alcohol 39:155-165.
5. Rodriguez T, Altieri A, Chatenoud L, Gallus S, Bosetti C, Negri E, Franceschi S, Levi F, Talamini R, La Vecchia C (2004) Oral Oncol 40:207-213.
6. Seitz HK, Matsuzaki S, Yokoyama A, Homann N, Vakevainen S, Wang XD (2001) Alcohol Clin Exp Res 25:1375-1435.
7. zur Hausen H (2000) J Natl Cancer Inst 92:690-698.
8. Gillison ML, Koch WM, Capone RB, Spafford M, Westra WH, Wu L, Zahurak ML, Daniel RW, Viglione M, Symer DE, et al. (2000) J Natl Cancer Inst 92:709-720.
9. Niedobitek G, Pitteroff S, Herbst H, Shepherd P, Finn T, Anagnostopoulos I, Stein H (1990) J Clin Pathol 43:918-921.
10. Snijders PJ, Cromme FV, van den Brule AJ, Schrijnemakers HF, Snow GB, Meijer CJ, Walboomers JM (1992) Int J Cancer 51:845-850.
11. Gillison ML (2004) Semin Oncol 31:744-754.
12. Scheffner M, Huibregtse JM, Vierstra RD, Howley PM (1993) Cell 75:495-505.
13. Werness BA, Levine AJ, Howley PM (1990) Science 248:76-79.
14. Huibregtse JM, Scheffner M, Howley PM (1991) EMBO J 10:4129-4135.
15. Boyer SN, Wazer DE, Band V (1996) Cancer Res 56:4620-4624.
16. Dyson N, Howley PM, Munger K, Harlow E (1989) Science 243:934-937.
17. Jones DL, Thompson DA, Munger K (1997) Virology 239:97-107.
18. Nguyen M, Song S, Liem A, Androphy E, Liu Y, Lambert PF (2002) J Virol 76:13039-13048.
19. Heck DV, Yee CL, Howley PM, Munger K (1992) Proc Natl Acad Sci USA 89:4442-4446.
20. Braakhuis BJ, Snijders PJ, Keune WJ, Meijer CJ, Ruijter-Schippers HJ, Leemans CR, Brakenhoff RH (2004) J Natl Cancer Inst 96:998-1006.
21. Smeets SJ, Braakhuis BJ, Abbas S, Snijders PJ, Ylstra B, van de Wiel MA, Meijer GA, Leemans CR, Brakenhoff RH (2006) Oncogene 25:2558-2564.
22. Song S, Pilot HC, Lambert PF (1999) J Virol 73:5887-5893.
23. Herber R, Liem A, Pitot H, Lambert PF (1996) J Virol 70:1873-1881.
24. Song S, Liem A, Miller JA, Lambert PF (2000) Virology 267:141-150.
25. Riley RR, Duensing S, Brake T, Munger K, Lambert PF, Arbeit JM (2003) Cancer Res 63:4862-4871.
26. Venkal JA, Shami S, Davis K, Nayak M, Plimmer JR, Pfeil R, Nair PP (1995) Environ Mol Mutagen 25:67-76.
27. Ramotar D, Belanger E, Brodeur I, Masson JY, Drobelsky EA (1998) J Biol Chem 273:21:489-496.
28. Kranendonk M, Pintado F, Mesquita P, Laires A, Vermeulen NP, Rueff J (1996) Mutagenesis 11:327-333.
29. Panigrahi GB, Walker IG (1990) Biochemistry 29:2122-2126.
30. Thomas DC, Husain I, Chaney SG, Panigrahi GB, Walker IG (1991) Nucleic Acids Res 19:365-370.
31. Tang XH, Knudsen B, Bemis D, Tickoo S, Gudas LJ (2004) Clin Cancer Res 10:301-313.
32. Brake T, Connor JP, Petereit DG, Lambert PF (2003) Cancer Res 63:8173-8180.
33. Song S, Gulliver GA, Lambert PF (1998) Proc Natl Acad Sci USA 95:2290-2295.
34. Lindel K, Beer KT, Laissue J, Greiner RH, Aebersold DM (2001) Cancer 92:805-813.
35. Schwartz SM, Daling JR, Doody DR, Wipf GC, Carter JJ, Madeleine MM, Mao EJ, Fitzgibbons ED, Huang S, Beckmann AM, et al. (1998) J Natl Cancer Inst 90:1626-1636.
36. Herrero R, Castellsague X, Pawlita M, Lissowska J, Kee F, Balaram P, Rajkumar T, Sridhar H, Rose B, Pintos J (2003) J Natl Cancer Inst 95:1772-1783.
37. Li SL, Kim MS, Cherrick HM, Doniger J, Park NH (1992) Carcinogenesis 13:1981-1987.
38. Liu X, Han S, Baluda MA, Park NH (1997) Oncogene 14:2347-2353.
39. Campo MS, O'Neil BW, Barron RJ, Jarrett WF (1994) Carcinogenesis 15:1597-1601.
40. Poetsch M, Lorenz G, Bankau A, Kleist B (2003) Head Neck 25:904-910.
41. Wilczynski SP, Lin BT, Xie Y, Paz IB (1998) Am J Pathol 152:145-156.
42. Weinberger PM, Yu Z, Haffty BG, Kowalski D, Harigopal M, Brandsma J, Sasaki C, Joe J, Camp RL, Rimm DL, Psyrri A (2006) J Clin Oncol 24:736-747.
43. Dahlgren L, Dahlstrand HM, Lindquist D, Hogmo A, Bjornestal L, Lindholm J, Lundberg B, Dalianis T, Munck-Wikland E (2004) Int J Cancer 112:1015-1019.
44. Loning T, Ikenberg H, Becker J, Gissmann L, Hoepfer I, zur Hausen H (1985) J Invest Dermatol 84:417-420.
45. Syrjanen K, Syrjanen S, Lamberg M, Pyrhonen S, Nuutinen J (1983) Int J Oral Surg 12:418-424.
46. Syrjanen KJ, Syrjanen SM, Lamberg MA, Happonen RP (1983) Arch Geschwulstforsch 53:537-546.
47. Syrjanen K (2006) in Papillomavirus Research: From Natural History to Vaccines and Beyond, ed Saveria Campo M (Caister Academic, Norfolk, UK), pp 229-254.
48. Begum S, Cao D, Gillison M, Zahurak M, Westra WH (2005) Clin Cancer Res 11:5694-5699.
49. Gillison ML, Lowy DR (2004) Lancet 363:1488-1489.
50. Balsitis SJ, Sage J, Duensing S, Munger K, Jacks T, Lambert PF (2003) Mol Cell Biol 23:9094-9103.